Pediatrix Medical Group Q2 2024 Adj. EPS $0.34 Beats $0.31 Estimate, Sales $504.296M Miss $505.495M Estimate
Portfolio Pulse from Benzinga Newsdesk
Pediatrix Medical Group (NYSE:MD) reported Q2 2024 adjusted EPS of $0.34, beating the estimate of $0.31, but sales of $504.296M missed the $505.495M estimate. EPS decreased by 12.82% YoY, while sales increased by 0.74% YoY.
August 06, 2024 | 10:02 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pediatrix Medical Group reported Q2 2024 adjusted EPS of $0.34, beating the estimate of $0.31, but sales of $504.296M missed the $505.495M estimate. EPS decreased by 12.82% YoY, while sales increased by 0.74% YoY.
The mixed results, with EPS beating estimates but sales missing slightly, suggest a neutral short-term impact on the stock price. The YoY decrease in EPS and slight increase in sales may balance each other out.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100